Callos Andrew sold CYTK
March 16, 2026 · Form 4 insider transaction
Callos Andrew sold 1,709 shares of Cytokinetics, Incorporated at $61.03 per share, a transaction worth $104.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,709
Price
$61.03
Total value
$104.3K
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 16, 2026
Filing dateMarch 16, 2026
Shares owned after46,149
OwnershipDirect
10b5-1 planNo
AmendedNo